Lapprovazione d a Novo nordisk un vantaggio rispetto alla rivale americana Eli Lilly, che sta sviluppando una propria pillola orale contro obesit e diabete, basata su orforglipron e prevista sul mercato statunitense non prima del marzo 2026 , ma ancora in attesa del via libera della Fda
Metabolic efficacy of time-restricted eating in adults: a systematic review and Meta-analysis of randomized controlled trials
Our findings have several implications for the expanding role of GLP-1 RAs in the management of obesity and cardiometabolic disease that underscore the need to understand patient perceptions to guide clinical decision-making, research, and policy efforts
While both groups had similar rates of adverse events (89% in the liraglutide group and 88% in the placebo group), the liraglutide group reported a higher incidence of gastrointestinal side effects due to dose escalations, however, none resulted in hospitalization
The blood is usually jet-black, similar to ink from a black ballpoint pen
Aspirin 81 mg, three times weekly Low-dose aspirin is widely used for its anti-inflammatory and blood-thinning properties, which may help reduce the risk of heart disease and stroke
